The Hematologist

The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.

170 episodi

One Size Doesn’t Fit All: International Consensus Recommendations for Pediatric Acute Myeloid Leukemia
6/11/2026
16:22
In this episode, contributing editor Dr. Lauren Pommert speaks with Dr. Sarah Tasian, pediatric oncologist at the Children’s Hospital of Philadelphia. They discuss the new International Consensus Recommendations for Pediatric Acute Myeloid Leukemia.
MonumenTAL and MajesTEC Steps Forward in Bispecific Antibodies for Relapsed Refractory Multiple Myeloma
26/10/2026
23:38
In this episode contributing editor Dr. Ajai Chari speaks with Dr. Roberto Mina, assistant professor of Hematology at Emory University about two recent myeloma studies published in the New England Journal of Medicine.
Non perdere nemmeno un episodio di “The Hematologist”. Iscriviti all'app gratuita GetPodcast.
One on One With Mary Horowitz
3/9/2026
23:33
In this episode contributing editor, Lori Muffly, MD, MS, speaks with a celebrated leader in the field of bone marrow transplantation, Mary Horowitz, MD, MS, of the Medical College of Wisconsin.
A Secondary Consideration: How Real-World Evidence Can Inform Practice in the Management of Patients With Secondary CNS Lymphoma
21/7/2026
21:32
In this episode, Contributing Editor, Brian Hill, MD, speaks with Juan Alderuccio, MD, of the University of Miami Cancer Center, about a landmark study that supports refined treatment approaches for secondary central nervous system large B-cell lymphoma.
Targeting the Lectin Pathway in Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy
16/6/2026
21:00
In this episode, Contributing Editor Meera Sridharan, MD, PhD, speaks with Hiroyuki Matsui, MD, PhD, assistant professor in the department of hematology at Kyoto University Hospital in Japan. Their conversation focuses on the role of narsoplimab in treating a potentially fatal hematologic disorder.
Search for the Fountain of Youth: Can Bispecific Antibodies Resurrect Dysfunctional T Cells to Improve Outcomes in Richter Transformation?
8/5/2026
17:35
In this episode, Contributing Editor Tycel Phillips, MD, speaks with Arnon Kater, MD, of Amsterdam University Medical Center in the Netherlands. Their conversation focuses on the potential role of bispecific antibodies in managing patients with Richter transformation.
Not All Clots Are Created Equal: Refining Secondary Prevention of Venous Thromboembolism in Higher-Risk Patients
30/4/2026
20:19
In this episode, Michael Scott, MD, from the University of Toronto, St. Michael’s Hospital, speaks with Samuel Wilson, MD, of the University of North Carolina at Chapel Hill. Their conversation focuses on recent trials examining secondary prevention of venous thromboembolism in higher-risk patients.
Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia
9/4/2026
21:53
In this episode, Contributing Editor Brian Hill, MD, PhD, speaks with Meghan Thompson, MD, of Memorial Sloan Kettering Cancer Center in New York. Their conversation focuses on Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia.
VERONA and the Future of High-Risk Myelodysplastic Syndromes: A Conversation With Dr. Jacqueline Garcia
9/3/2026
22:21
In this episode, Contributing Editor Charlotte Brierley, MD, PhD, speaks with Jacqueline Garcia, MD, assistant professor at the Dana Farber Cancer Institute and Harvard Medical School and an expert in myeloid neoplasms. Their discussion focuses on the VERONA trial and its impact on the myelodysplastic syndromes community.
Leading With Lived Experience: Dr. Brian Koffman, Patient and CEO of the CLL Society
5/2/2026
22:35
In this episode Contributing Editor Brian Hill, MD, talks with Brian Koffman, MDCM, retired family doctor and chronic lymphocytic leukemia patient. Dr. Koffman is co-founder and chief medical officer of the CLL Society. They discuss Dr. Koffman’s journey as both a physician and a patient.

Altri episodi

Accedi a tutto il mondo dei podcast con l’app gratuita GetPodcast.

Iscriviti ai tuoi podcast preferiti, ascolta gli episodi offline e ricevi fantastici consigli.

Un'azienda di

The Hematologist

The Hematologist

170 episodi

One Size Doesn’t Fit All: International Consensus Recommendations for Pediatric Acute Myeloid Leukemia

MonumenTAL and MajesTEC Steps Forward in Bispecific Antibodies for Relapsed Refractory Multiple Myeloma

One on One With Mary Horowitz

A Secondary Consideration: How Real-World Evidence Can Inform Practice in the Management of Patients With Secondary CNS Lymphoma

Targeting the Lectin Pathway in Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy

Search for the Fountain of Youth: Can Bispecific Antibodies Resurrect Dysfunctional T Cells to Improve Outcomes in Richter Transformation?

Not All Clots Are Created Equal: Refining Secondary Prevention of Venous Thromboembolism in Higher-Risk Patients

Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia

VERONA and the Future of High-Risk Myelodysplastic Syndromes: A Conversation With Dr. Jacqueline Garcia

Leading With Lived Experience: Dr. Brian Koffman, Patient and CEO of the CLL Society